Cargando…

Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and intraocular inflammation

PURPOSE: To describe angiographic features of a case of delayed-onset retinal vascular occlusion and intraocular inflammation (IOI) following brolucizumab intravitreal injection (IVI). OBSERVATIONS: A 75-year-old woman with advanced age-related macular degeneration (AMD) complained of persistent dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kusuhara, Sentaro, Kim, Kyung Woo, Miki, Akiko, Nakamura, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026644/ https://www.ncbi.nlm.nih.gov/pubmed/35464682 http://dx.doi.org/10.1016/j.ajoc.2022.101521

Ejemplares similares

Cystotomy with or without fibrinogen clot removal for refractory cystoid macular edema secondary to branch retinal vein occlusion
por: Yamada, Hiroko, et al.
Publicado: (2021)

Effects of Elevated Intraocular Pressure on Retinal Ganglion Cell Density and Expression and Interaction of Retinal Aquaporin 9 and Monocarboxylate Transporters
por: Murai, Yusuke, et al.
Publicado: (2023)

Imaging Features of Retinal Vasculitis and/or Retinal Vascular Occlusion after Brolucizumab Treatment in the Postmarketing Setting
por: Grewal, Dilraj S., et al.
Publicado: (2023)

Usefulness of intraoperative optical coherence tomography to minimize the intraocular lens tilt during the intrascleral fixation: a clinical and experimental evaluation
por: Sotani, Yasuyuki, et al.
Publicado: (2023)

Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration
por: Haug, Sara J., et al.
Publicado: (2020)

Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy
por: Miki, Akiko, et al.
Publicado: (2021)

Aqp9 Gene Deletion Enhances Retinal Ganglion Cell (RGC) Death and Dysfunction Induced by Optic Nerve Crush: Evidence that Aquaporin 9 Acts as an Astrocyte-to-Neuron Lactate Shuttle in Concert with Monocarboxylate Transporters To Support RGC Function and Survival
por: Mori, Sotaro, et al.
Publicado: (2020)

Trends in the Cumulative Post-Marketing Reporting Rates of Retinal Vasculitis and/or Retinal Vascular Occlusion and Associated Vision Loss with Brolucizumab
por: Igwe, Franklin, et al.
Publicado: (2022)

The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation
por: Shigemoto, Yumi, et al.
Publicado: (2021)

Vitreous Noise on Optical Coherence Tomography as an Early Finding of Brolucizumab-Related Intraocular Inflammation
por: Yoshikawa, Yuji, et al.
Publicado: (2021)

Impaired Retinal Circulation during Axitinib Treatment for Metastatic Renal Cell Carcinoma
por: Kimura, Masashi, et al.
Publicado: (2019)

Peripheral Fluorescein Angiographic Findings in Fellow Eyes of Patients with Branch Retinal Vein Occlusion
por: Tsui, Irena, et al.
Publicado: (2013)

Cerebral Angiographic Findings of Cosmetic Facial Filler-related Ophthalmic and Retinal Artery Occlusion
por: Kim, Yong-Kyu, et al.
Publicado: (2015)

A case of panuveitis and retinal vasculitis associated with pembrolizumab therapy for metastatic lung cancer
por: Kim, Kyung Woo, et al.
Publicado: (2021)

Removal of Sub-Internal Limiting Membrane Hemorrhage Secondary to Retinal Arterial Macroaneurysm Rupture: Internal Limiting Membrane Non-Peeling Technique
por: Kimura, Akari, et al.
Publicado: (2023)

Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations
por: Jain, Atul, et al.
Publicado: (2020)

Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema
por: Hirano, Takao, et al.
Publicado: (2022)

Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
por: Kusuhara, Sentaro, et al.
Publicado: (2023)

RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence
por: Wykoff, Charles C., et al.
Publicado: (2023)

Angiographic Risk Features of Branch Retinal Vein Occlusion Onset as Determined by Optical Coherence Tomography Angiography
por: Kogo, Takahiro, et al.
Publicado: (2020)

Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Clinical Factors Associated with Low-Contrast Visual Acuity after Reduced-Fluence Photodynamic Therapy in Patients with Resolved Central Serous Chorioretinopathy and Good Baseline Visual Acuity
por: Chubachi, Aya, et al.
Publicado: (2021)

Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection
por: Kusuhara, Sentaro, et al.
Publicado: (2020)

Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
por: Khoramnia, Ramin, et al.
Publicado: (2021)

Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Autologous Scleral Pocket Technique for Ahmed Glaucoma Valve Implantation with Pars Plana Tube Insertion for Neovascular Glaucoma
por: Maki, Hitomi, et al.
Publicado: (2021)

Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration
por: Kishi, Maya, et al.
Publicado: (2023)

Swept-source optical coherence tomography angiography of retinal occlusive vasculitis following brolucizumab administration: a case report
por: Lee, Eun Kyoung, et al.
Publicado: (2022)

Intravitreal Injection of Brolucizumab for Recalcitrant Macular Edema due to Central Retinal Vein Occlusion: A Small Case Series
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment
por: Ueji, Natsuki, et al.
Publicado: (2023)

Brolucizumab and immunogenicity
por: Sharma, Ashish, et al.
Publicado: (2020)

Retinal pigment epithelial tear following intravitreal injection of brolucizumab
por: Ashkenazy, Noy, et al.
Publicado: (2021)

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model
por: Schubert, William, et al.
Publicado: (2022)

The choroidal structure changes in a case with hypertensive choroidopathy
por: Sakai, Daiki, et al.
Publicado: (2020)

Factors associated with the development of ocular candidiasis and ocular prognosis with echinocandin therapy for candidemia
por: Sakai, Daiki, et al.
Publicado: (2021)

Brolucizumab for macular degeneration
Publicado: (2020)

Side Effects of Brolucizumab
por: Motevasseli, Tahmineh, et al.
Publicado: (2021)

Indocyanine green angiographic findings in seven eyes with vasoproliferative retinal tumor
por: Matsuura, Saya, et al.
Publicado: (2020)

Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study
por: Maruko, Ichiro, et al.
Publicado: (2021)

Intraocular inflammation secondary to intravitreal brolucizumab treated successfully with Sub-Tenon triamcinolone: A case report
por: Kurup, Shree K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ojnb4ncjkfodek9b3qcds5nsm6